Mark Juckett

12PUBLICATIONS
92CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 01, 2026
Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" Trial.

|Jun 09, 2026
Donor-specific transplant outcomes from BMT CTN 1702: a multicenter prospective biologic assignment trial.

|Jun 02, 2026
Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia.

|Jan 27, 2026
Targeting Aurora kinase A to prevent GVHD and relapse after myeloablative allogeneic hematopoietic cell transplantation.

Shernan G Holtan, Punita Grover, Kelly Walton

|Sep 18, 2025
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.

Stephanie J Lee, Brent Logan, Mary M Horowitz

|Jun 24, 2025
Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice.

Neel S Bhatt, Azra Borogovac, Yvonne A Efebera

Pageof 2

Frequent Collaborators

3 joint publications

Stephanie J Lee

2 joint publications

Jason G Dehn

2 joint publications

Stefan O Ciurea

2 joint publications

Steven M Devine